Skip to main content
. 2022 May 26;14(11):2648. doi: 10.3390/cancers14112648

Figure 5.

Figure 5

Gallic acid could be explored for patients with CRC as therapy. (A) ΔCt results for POLR1A and CMYC obtained by qRT-PCR in the cohort of patients with CRC. (B) Analysis of POLR1A and CMYC expression levels in Oncomine database with “TCGA Colorectal” dataset including non-tumoral (N = 22) and tumoral (N = 101) samples. For all tests, p-values below 0.05 were considered significant and expressed as follows: * p < 0.05 and ** p < 0.01.